Effect of tamsulosin on ureteric stent related morbidity: a double-blind randomized placebo-controlled study
| Autor: | Anuj Rattan, Gurpreet Singh Bhangu, Ripudaman Singh, Darpan Bansal |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
business.industry Visual analogue scale medicine.medical_treatment Urology Placebo-controlled study medicine.disease Placebo Ureter medicine.anatomical_structure Tamsulosin Lower urinary tract symptoms Medicine Dysuria medicine.symptom business Ureteric stent medicine.drug |
| Zdroj: | International Surgery Journal. 8:294 |
| ISSN: | 2349-2902 2349-3305 |
| DOI: | 10.18203/2349-2902.isj20205822 |
| Popis: | Background: Post ureteral stenting, symptoms occurs of lower urinary tract which impact quality of life in around 80% of patients, urgency, frequency, dysuria, suprapubic pain, hematuria. α1-Adrenoceptors are found in highest density in the distal ureter. α1-Adrenoceptor antagonists dilates the lumen of the ureter and reduces the spasms by decreasing the peristaltic frequency and inhibiting basal tone of the ureter, leading to improvement in stent-related symptoms. This study was conducted to study effect of tamsulosin, a selective α1A- and α1D-adrenoceptor antagonist in relieving ureteric stent related symptomsMethods: A randomized double blinded placebo-controlled study conducted from February 2019 to August 2020 in Department of Surgery SGRD University, Amritsar. We enrolled 60 patients with each group of 30 patients (Group A placebo and Group B Tamsilosin 0.4 mg). IPSS (irritative and obstructive), quality of life (QoL) and visual analog scale VAS) pain score were calculated based on post-operative day one versus at Stent removal day (Post-operative day 21) at 3 weeks observations. analysis was done using Statistical package for social sciences (SPSS) version 23.0. Student ‘t’test (unpaired) and Chi-square test.Results: IPSS, QoL and VAS showed improvement with significant relieve of symptoms in patients on tamsulosin compared to placebo at time of stent removal.Conclusions: The study concluded that administration of tamsulosin a selective α1-blocker is useful in decreasing lower urinary tract symptoms in patients undergoing ureteral stenting. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|